331 related articles for article (PubMed ID: 33931318)
1. Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis.
Gözüküçük A; Kılıç M; Çakıroğlu B
J Pediatr Urol; 2021 Aug; 17(4):451.e1-451.e6. PubMed ID: 33931318
[TBL] [Abstract][Full Text] [Related]
2. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
Berkenwald A; Pires J; Ellsworth P
J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy (desmopressin plus oxybutynin) improves the response rate compared with desmopressin alone in patients with monosymptomatic nocturnal enuresis and nocturnal polyuria and absence of constipation predict the response to this treatment.
Capalbo D; Guarino S; Di Sessa A; Esposito C; Grella C; Papparella A; Miraglia Del Giudice E; Marzuillo P
Eur J Pediatr; 2023 Apr; 182(4):1587-1592. PubMed ID: 36693995
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial.
Ezodin N; Sarouei M; Khademlo M; Milani SH; Yousefi S; Mohammadjafari H
Ethiop J Health Sci; 2023 Jul; 33(4):611-620. PubMed ID: 38784212
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
8. Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics).
Deshpande AV; Caldwell PH; Sureshkumar P
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002238. PubMed ID: 23235587
[TBL] [Abstract][Full Text] [Related]
9. Desmopressin response in nocturnal enuresis showing concentrated urine.
Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
Pediatr Int; 2020 Jun; 62(6):701-704. PubMed ID: 32065484
[TBL] [Abstract][Full Text] [Related]
10. A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis.
Mello MF; Locali RF; Araujo RM; Reis JN; Saiovici S; Mello LF; Trigo Rocha FE
J Pediatr Urol; 2023 Jun; 19(3):241-246. PubMed ID: 36717289
[TBL] [Abstract][Full Text] [Related]
11. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
Radvanska E; Kovács L; Rittig S
J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of desmopressin fast-melting formulation and enuretic alarm in the treatment of monosymptomatic nocturnal enuresis.
Keten T; Aslan Y; Balci M; Erkan A; Senel C; Oguz U; Kayali M; Guzel O; Karabulut E; Tuncel A
J Pediatr Urol; 2020 Oct; 16(5):645.e1-645.e7. PubMed ID: 32826183
[TBL] [Abstract][Full Text] [Related]
13. Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial.
Lee T; Suh HJ; Lee HJ; Lee JE
J Urol; 2005 Sep; 174(3):1084-7. PubMed ID: 16094064
[TBL] [Abstract][Full Text] [Related]
14. Partial response to intranasal desmopressin in children with monosymptomatic nocturnal enuresis is related to persistent nocturnal polyuria on wet nights.
Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle C; Vansintjan P; Donckerwolcke R; Vande Walle J
J Urol; 2007 Sep; 178(3 Pt 1):1048-51; discussion 1051-2. PubMed ID: 17632162
[TBL] [Abstract][Full Text] [Related]
15. Evidence of reduced bladder capacity during nighttime in children with monosymptomatic nocturnal enuresis.
Borg B; Kamperis K; Olsen LH; Rittig S
J Pediatr Urol; 2018 Apr; 14(2):160.e1-160.e6. PubMed ID: 29174376
[TBL] [Abstract][Full Text] [Related]
16. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
Ikeda H; Watanabe T; Isoyama K
Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of nocturnal enuresis with desmopressin and indomethacin.
Kamperis K; Hagstroem S; Faerch M; Mahler B; Rittig S; Djurhuus JC
Pediatr Nephrol; 2017 Apr; 32(4):627-633. PubMed ID: 27787700
[TBL] [Abstract][Full Text] [Related]
18. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
Tauris LH; Andersen RF; Kamperis K; Hagstroem S; Rittig S
J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
[TBL] [Abstract][Full Text] [Related]
19. Combined laser acupuncture and desmopressin for treating resistant cases of monosymptomatic nocturnal enuresis: a randomized comparative study.
Moursy EE; Kamel NF; Kaseem AF
Scand J Urol; 2014 Dec; 48(6):559-64. PubMed ID: 24909996
[TBL] [Abstract][Full Text] [Related]
20. Association between winter season and desmopressin treatment efficiency in children with monosymptomatic nocturnal enuresis: a pilot study.
Sun M; Li S; Sun X; Deng Z; Xu Y
Int Braz J Urol; 2022; 48(2):275-281. PubMed ID: 35170888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
